{"disease":{"id":"extranodal-natural-killer-t-cell-lymphoma-nasal-type","name":"extranodal natural killer t cell lymphoma nasal type"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04288726","title":"Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"Baylor College of Medicine","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}